AZPAMIN™
81 mg enteric coated tablets 30 200
registration number
56/8/0993
What AZPAMIN™ is and what it is used for
Indications related to inhibition of platelet aggregation:
To reduce the risk of myocardial infarction in patients with unstable angina or in patients who have had a previous myocardial infarction. To reduce the risk of recurrent transient ischaemic attacks or stroke in men who have had transient ischaemia of the brain due to fibrin platelet emboli. To reduce the risk of graft occlusion following aorta coronary by-pass surgery.
dosage
For inhibition of platelet aggregation:
Adults:
One to three tablets as directed by the doctor to be taken every day, preferably at the same time each day.
Warning:
The optimal dose for inhibition of platelet aggregation in humans is not known. Do not use this product for indications related to the inhibition of platelet aggregation unless directed by a doctor.
how to take
For oral administration in adults only.
What AZPAMIN™ contains
Each enteric coated tablet contains 81 mg aspirin.
other ingredients
Tablet: Cross Carmellose Sodium, Isopropyl Alcohol, Microcrystalline cellulose, Pregelatinised maize starch, Purified Talc, Sodium Lauryl sulphate.
Enteric coating: Wincoat WT-TR-5002, Wincoat WT-NAQ-6015 Orange.
Therapeutic classification
B01AC06: Antithrombotic agents: platelet aggregation inhibitors excl. heparin. A 8 Medicines acting on the blood and haemopoietic system.